<\/span><\/h2>The Goldline Pharmaceutical IPO listing on 19 May 2026 is set to be one of the strongest SME IPO listings of May 2026, anchored by 840 times subscription, GMP of Rs 17 to Rs 18 implying a Rs 60 to Rs 61 listing price, 56 per cent FY25 PAT growth and a 27.38 per cent RoNW. Allottees targeting listing gains should plan their exit in the first 10 to 30 minutes of the Goldline Pharmaceutical IPO listing. Medium term investors can hold for the 6 to 12 month fundamental re-rating story if PAT growth continues above 40 per cent. Track the live listing price from 10:00 AM IST on 19 May 2026 on the Univest Screener.<\/p>
Disclaimer: <\/strong>This article is for educational and informational purposes only and does not constitute investment advice. Univest is a SEBI-registered research analyst (Uniresearch Global Pvt Ltd, INH000012449). IPO investments are subject to market risk. Grey Market Premium (GMP) is unofficial and unregulated by SEBI. Please read the Red Herring Prospectus carefully before investing. Past performance does not guarantee future results. Consult a SEBI-registered financial advisor before making any investment decision.<\/em><\/p><\/span>FAQs<\/strong><\/span><\/h2><\/span>What is the Goldline Pharmaceutical IPO listing date?<\/strong><\/span><\/h3>Ans. The Goldline Pharmaceutical IPO listing date is 19 May 2026 on the BSE SME platform.<\/strong> Shares are credited to allottees’ demat accounts on 18 May 2026. Trading begins at 10:00 AM IST on 19 May 2026 as the Goldline Pharmaceutical IPO listing day open.<\/p><\/span>What is the expected listing price of Goldline Pharmaceutical IPO?<\/strong><\/span><\/h3>Ans. Based on the GMP of Rs 17-18 as of 14 May 2026, the Goldline Pharmaceutical IPO listing price is expected around Rs 60-61.<\/strong> This implies a listing gain of approximately 39 to 41 per cent above the issue price of Rs 43. GMP is unofficial and actual Goldline Pharmaceutical IPO listing prices may differ significantly.<\/p><\/span>Why was the Goldline Pharmaceutical IPO subscribed 840 times?<\/strong><\/span><\/h3>Ans. The Goldline Pharmaceutical IPO was subscribed 840.74 times overall because of its small issue size of Rs 11.61 crore,<\/strong> attractive PE of 13.93 times, strong RoNW of 27.38 per cent and 56 per cent PAT growth in FY25. The NII category alone subscribed 1,662 times, driven by aggressive HNI bidding for listing gains at the Goldline Pharmaceutical IPO listing.<\/p><\/span>Should I sell on listing day or hold Goldline Pharmaceutical shares?<\/strong><\/span><\/h3>Ans. Listing gain investors should consider selling in the first 10-30 minutes of the Goldline Pharmaceutical IPO listing<\/strong> if the stock opens at or above the GMP level of Rs 60. Long term investors with 6-12 month horizon can hold for further re-rating if PAT growth continues above 40 per cent. Consult a SEBI-registered advisor before making this decision.<\/p><\/span>What is Goldline Pharmaceutical’s business model?<\/strong><\/span><\/h3>Ans. Goldline Pharmaceutical is an asset-light pharma marketing company that does not manufacture medicines directly.<\/strong> It partners with third-party manufacturers to supply 42-plus products under the Goldline brand across five divisions covering cardiology, diabetology, paediatrics, critical care and oncology. The company distributes across Maharashtra, MP, Odisha, Jharkhand, Tamil Nadu, Rajasthan and Bihar.<\/p>","protected":false},"excerpt":{"rendered":"The Goldline Pharmaceutical IPO listing on 19 May 2026 on the BSE SME platform is among the most anticipated SME IPO listings of May 2026, after the issue recorded a blockbuster subscription of 840.74 times overall, with NII investors subscribing 1,662 times and retail investors subscribing 881 times the reserved portion. The Goldline Pharmaceutical IPO<\/p>\n","protected":false},"author":34,"featured_media":89848,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1281],"tags":[4106],"class_list":["post-89847","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ipo","tag-ipo-listing-preview"],"metadata":{"_edit_lock":["1779007692:23"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"rank_math_primary_category":["1281"],"rank_math_seo_score":["76"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"rank_math_title":["Goldline Pharmaceutical IPO Listing Preview 19 May 2026 | GMP 39%"],"rank_math_description":["Goldline Pharmaceutical IPO listing on 19 May 2026 on BSE SME. Subscribed 840x, GMP Rs 17-18, expected listing Rs 60-61. Full preview, financials and strategy."],"rank_math_focus_keyword":["Goldline Pharmaceutical IPO"],"_thumbnail_id":["89848"],"_edit_last":["23"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["11887"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/05\/17141647\/Goldline-Pharmaceutical-1.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/89847","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/34"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=89847"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/89847\/revisions"}],"predecessor-version":[{"id":89849,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/89847\/revisions\/89849"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/89848"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=89847"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=89847"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=89847"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}